Investor Relations Growth and Delivery

Filter by Year

2015 | 2014 | 2013

Keyword Search
 

2015 News Releases

 Previous | Next
January 26, 2015
Teva Receives FDA Approval for First Generic Nexium® Delayed-Release Capsules in the United States
JERUSALEM--(BUSINESS WIRE)--Jan. 26, 2015-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the Food and Drug Administration (FDA) approval of the first generic equivalent to Nexium (esomeprazole magnesium) Delayed-Release Capsules in the United States. Teva is preparing to launch the product in the near future. Nexium Delayed-Release Capsules, marketed by AstraZeneca, had annual sales of approximately $6 billion in the U  Read More »
January 20, 2015
Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE® 20 mg/mL Case and Remand for Further Review
Positive Decision Requires Federal Circuit to Reconsider its Invalidity Ruling in the Case, Teva Pharmaceuticals USA, Inc. et al. Petitioners v. Sandoz Inc. et al. regarding Teva’s ‘808 Patent JERUSALEM--(BUSINESS WIRE)--Jan. 20, 2015-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced the U.S. Supreme Court’s decision in Teva Pharmaceuticals USA, Inc. et al. Petitioners v. Sandoz Inc. et al. that reversed the Federal Circuit Cou  Read More »
January 15, 2015
Teva to Report Fourth Quarter 2014 Financial Results on February 5, 2015
JERUSALEM--(BUSINESS WIRE)--Jan. 15, 2015-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that it will release its fourth quarter 2014 financial results on Thursday, February 5, 2015 at 7:00 a.m. ET. Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its fourth quarter 2014 results and overall business environment. A Question & Answer session will follow this discussion.   Read More »
January 08, 2015
Teva to Present at the 33rd Annual J.P. Morgan Healthcare Conference
JERUSALEM--(BUSINESS WIRE)--Jan. 8, 2015-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the 33rd Annual J.P. Morgan Healthcare Conference. Erez Vigodman, President & CEO will present on Tuesday, January 13, 2015 at 3:30 PM PST. What:     Teva Presentation at the 33rd Annual J.P.  Read More »
January 06, 2015
Teva Launches Generic Diovan® in the United States
JERUSALEM--(BUSINESS WIRE)--Jan. 6, 2015-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the Food and Drug Administration (FDA) approval and the launch of the generic equivalent to Diovan® (Valsartan) Tablets in the United States. Diovan® (Valsartan) Tablets, marketed by Novartis Pharmaceuticals, had annual sales of approximately $1.8 billion in the United States, according to IMS data as of October 2014. About T  Read More »
 Previous | Next